U.S. Markets

US BROKER MOVES: META upgraded at Arete; SHW downgraded at UBS

News detail

UPGRADES Abivax (ABVX) Upgraded from Underperform to Neutral at Wedbush Atlas Energy Solutions (AESI) Upgraded from Market Perform to Outperform at Raymond James; PT USD 25.00 Eagle Materials (EXP) Upgraded from Underweight to Neutral at JPMorgan; PT USD 225.00 Guardant Health (GH) Upgraded from In Line to Outperform at Evercore ISI; PT USD 160.00 Hewlett Packard Enterprise (HPE) Upgraded from Hold to Buy at Loop Capital Knight-Swift Transportation (KNX) Upgraded from Neutral to Positive at Susquehanna Macerich (MAC) Upgraded from Hold to Buy at Deutsche Bank; PT USD 27.00 (prev. USD 20.00) Meta Platforms (META) Upgraded from Neutral to Buy at Arete; PT USD 735.00 OPTU (OPTU) Upgraded from Underperform to Neutral at BNP Paribas Exane Tripadvisor (TRIP) Upgraded from Neutral to Outperform at Wedbush; PT USD 19.00 (prev. USD 12.00) DOWNGRADES Abivax (ABVX) Downgraded from Buy to Hold at Jefferies; PT USD 90.00 (prev. USD 160.00) Consolidated Edison (ED) Downgraded from Outperform to Neutral at Mizuho; PT USD 105.00 Fulcrum Therapeutics (FULC) Downgraded from Overweight to Underweight at Piper Sandler; PT USD 3.00 (prev. USD 23.00) Fulcrum Therapeutics (FULC) Downgraded from Outperform to Market Perform at Leerink; PT USD 4.00 Fulcrum Therapeutics (FULC) Downgraded from Buy to Neutral at H.C. Wainwright; PT USD 3.00 (prev. USD 25.00) Fulcrum Therapeutics (FULC) Downgraded from Buy to Hold at Truist Securities; PT USD 4.00 (prev. USD 17.00) Fulcrum Therapeutics (FULC) Downgraded from Buy to Hold at Stifel; PT USD 3.00 (prev. USD 25.00) Intuit (INTU) Downgraded from Neutral to Sell at Goldman Sachs; PT USD 276.00 Nu Holdings (NU) Downgraded from Neutral to Underperform at BofA Securities; PT USD 10.00 (prev. USD 16.00) Okta (OKTA) Downgraded from Outperform to Neutral at Mizuho; PT USD 125.00 (prev. USD 110.00) StandardAero (SARO) Downgraded from Buy to Hold at Jefferies; PT USD 30.00 (prev. USD 34.00) Sherwin-Williams (SHW) Downgraded from Buy to Neutral at UBS; PT USD 330.00 (prev. USD 385.00) Sociedad Quimica y Minera de Chile (SQM) Downgraded from Overweight to Neutral at JPMorgan; PT USD 100.00 (prev. USD 94.00) Taylor Morrison Home (TMHC) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 72.50 Taylor Morrison Home (TMHC) Downgraded from Buy to Hold at Truist Securities; PT USD 72.50 INITIATIONS Asset Entities (ASST) Initiated with Buy at Benchmark, PT USD 32/shr CoreWeave (CRWV) Initiated with Outperform at BNP Paribas Exane, PT USD 192/shr Enhabit (ENHA) Initiated with Buy at Canaccord, PT USD 6/shr FDXF (FDXF) Initiated with Hold at Truist Securities, PT USD 155/shr MANE (MANE) Initiated with Buy at Needham, PT USD 136/shr Mirum Pharmaceuticals (MIRM) Initiated with Buy at Citi, PT USD 145/shr Martin Marietta Materials (MLM) Initiated with Hold at Berenberg, PT USD 556/shr MOBI (MOBI) Initiated with Overweight at JPMorgan, PT USD 15/shr MOBI (MOBI) Initiated with Outperform at Wolfe Research, PT USD 19/shr MOBI (MOBI) Initiated with Buy at Goldman Sachs, PT USD 31/shr MOBI (MOBI) Initiated with Buy at BTIG, PT USD 19/shr MOBI (MOBI) Initiated with Buy at BofA Securities, PT USD 16/shr Nebius Group (NBIS) Initiated with Neutral at BNP Paribas Exane, PT USD 255/shr Neurocrine Biosciences (NBIX) Initiated with Buy at Goldman Sachs, PT USD 213/shr Octave Bioscience (OCTV) Initiated with Sector Perform at RBC Capital, PT USD 21/shr ODTX (ODTX) Initiated with Overweight at JPMorgan, PT USD 26/shr ODTX (ODTX) Initiated with Overweight at Cantor Fitzgerald ODTX (ODTX) Initiated with Outperform at Oppenheimer, PT USD 40/shr ODTX (ODTX) Initiated with Outperform at Wedbush, PT USD 30/shr ODTX (ODTX) Initiated with Buy at TD Cowen Take-Two Interactive (TTWO) Initiated with Overweight at Piper Sandler, PT USD 280/shr Unity Software (U) Initiated with Overweight at Piper Sandler, PT USD 40/shr Vulcan Materials (VMC) Initiated with Hold at Berenberg, PT USD 283/shr X4 Pharmaceuticals (XFOR) Initiated with Outperform at Leerink, PT USD 12/shr

34 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more